BioVaxys Technology Corp.
Get Full AccessDescription
- BioVaxys (CSE:BIOV, OTC:LMNGF) is a clinical stage biotechnology company that is developing its viral and oncology vaccine platforms for SARS-CoV-2 and various cancers.
-
Headquarters:150 Radnor Chester Rd , , Pennsylvania, United States
More -
Phone Number:
-
Website: http://www.biovaxys.com
-
Employees:3
-
Revenue:$1 - 10M
-
Legal Name:BioVaxys Technology Corp.
-
BioVaxys Technology Corp.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding BioVaxys Technology Corp.
-
Where are BioVaxys Technology Corp.'s Headquarters?
BioVaxys Technology Corp.'s Headquarters are in 150 Radnor Chester Rd ,,Pennsylvania,United States
-
What is BioVaxys Technology Corp.'s official website?
BioVaxys Technology Corp.'s official website is http://www.biovaxys.com
-
What is BioVaxys Technology Corp.'s Revenue?
BioVaxys Technology Corp.'s revenue is $1 - 10M
-
What is BioVaxys Technology Corp.'s NAICS code?
BioVaxys Technology Corp.'s NAICS code is 541713
-
How many employees are working in BioVaxys Technology Corp.
BioVaxys Technology Corp. has 3 employees
-
What is BioVaxys Technology Corp.'s Industry?
BioVaxys Technology Corp. is in the industry of Biotechnology
-
Who is BioVaxys Technology Corp.'s Chief Financial Officer?
BioVaxys Technology Corp.'s Chief Financial Officer is Lachlan Mcleod

